In 2023, the re-import value of O-Acetylsalicylic Acid to France was recorded at $125.93 thousand USD. Over the forecast period from 2024 to 2028, a consistent downward trend in re-importations is observed, with values decreasing from $121.94 thousand USD in 2024 to $106.74 thousand USD in 2028. This reflects a steady year-on-year decline, averaging a compound annual growth rate (CAGR) of -3.2%.
Future trends to watch for include potential shifts in global supply chains that could impact re-imports and domestic policy changes affecting import tariffs. Changes in global demand for pharmaceuticals may also alter import dynamics.
